Skip to content
HowShorted

Vera Therapeutics, Inc. Class short interest in 2026

In 2026, Vera Therapeutics, Inc. Class's disclosed short interest ran from 12.59% of shares outstanding on 15 Jan 2026 to 23.64% on 15 Sep 2026, a change of +11.05 percentage points. The year's high was 27.58% on 31 Aug 2026 and its low 11.95% on 27 Feb 2026, averaging 17.02% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.18 days on 29 May 2026. Full history: Vera Therapeutics, Inc. Class.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Vera Therapeutics, Inc. Class in 2026

2026 in figures

Start of year
12.59% (15 Jan 2026)
End of year
23.64% (15 Sep 2026)
Change
+11.05 pp
High
27.58% (31 Aug 2026)
Low
11.95% (27 Feb 2026)
Average
17.02%
Highest days to cover
11.18 (29 May 2026)
SEC filings marked
6

Every report in 2026

Vera Therapeutics, Inc. Class short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202612.59%7.03
30 Jan 202612.66%7.83
13 Feb 202612.57%8.28
27 Feb 202611.95%8.1510-K filed, results (8-K)
13 Mar 202612.91%6.19
31 Mar 202615.27%7.85
15 Apr 202615.44%6.93
30 Apr 202614.68%9.50
15 May 202614.04%9.9810-Q filed, results (8-K)
29 May 202615.09%11.18
15 Jun 202616.49%10.40
30 Jun 202618.84%5.87
15 Jul 202621.01%4.99
31 Jul 202621.21%9.42
14 Aug 202623.33%6.9510-Q filed, results (8-K)
31 Aug 202627.58%10.81
15 Sep 202623.64%6.18

See also: Vera Therapeutics, Inc. Class's full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.